Go Pro
→ Here’s Why Trump Won’t End The Iran War (From Banyan Hill Publishing) (Ad)tc pixel Free DBVT Stock Alerts

DBV Technologies (DBVT) Financials

DBV Technologies logo
$13.90 +0.27 (+1.98%)
Closing price 07/27/2026 04:00 PM Eastern
Extended Trading
$13.92 +0.03 (+0.18%)
As of 07/27/2026 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for DBV Technologies

Annual Income Statements for DBV Technologies

This table shows DBV Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -49 -120 -177 -190 -172 -160 -110 -104 -67 -118 -140
Consolidated Net Income / (Loss)		 -49 -120 -177 -190 -172 -160 -98 -96 -73 -114 -147
Net Income / (Loss) Continuing Operations		 -49 -120 -177 -190 -172 -160 -98 -96 -73 -114 -147
Total Pre-Tax Income 		-49 -120 -177 -190 -171 -160 -98 -96 -73 -114 -146
Total Operating Income		 -49 -122 -174 -190 -171 -158 -99 -97 -76 -117 -147
Total Gross Profit		 6.56 9.56 14 17 15 11 5.71 4.84 16 4.15 5.64
Total Revenue		 6.70 9.56 14 17 15 11 5.71 4.84 16 4.15 5.64
Operating Revenue		 0.22 0.00 0.00 0.00 15 0.00 5.71 4.84 16 4.15 5.64
Total Cost of Revenue		 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 56 132 188 207 186 169 104 101 92 121 153
Selling, General & Admin Expense		 18 37 43 47 49 45 31 24 30 29 33
Marketing Expense		 0.53 12 19 37 22 - 4.39 1.61 2.44 2.66 3.22
Research & Development Expense		 37 83 126 123 115 101 70 76 60 89 117
Total Other Income / (Expense), net		 0.95 1.58 -3.25 0.16 -0.38 -1.73 0.43 0.43 3.71 2.73 0.60
Interest & Investment Income		 1.11 1.59 0.74 0.56 - 0.24 0.43 0.43 3.71 2.73 0.60
Income Tax Expense		 0.00 0.00 0.00 0.02 0.61 -0.01 -0.38 0.07 0.01 0.06 0.49
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - - - - 12 8.17 -5.67 4.06 -6.76
Basic Earnings per Share		 - - - - ($4.65) $2.95 ($1.78) ($1.24) ($0.76) ($1.17) ($1.05)
Weighted Average Basic Shares Outstanding		 - - 24.99M 30.16M 54.94M 54.09M 54.92M 77.38M 95.12M 97.00M 139.57M
Diluted Earnings per Share		 - - - - ($4.65) $2.95 ($1.78) ($1.24) ($0.76) ($1.17) ($1.05)
Weighted Average Diluted Shares Outstanding		 - - 24.99M 30.16M 54.94M 54.09M 54.92M 77.38M 95.12M 97.00M 139.57M
Weighted Average Basic & Diluted Shares Outstanding		 - - 24.99M 30.16M 37.01M 54.09M 54.92M 94.14M 96.43M - 296.04M

Quarterly Income Statements for DBV Technologies

This table shows DBV Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -4.94 -30 -34 -27 -27 -26 -35 -34 -45 -52 -51
Consolidated Net Income / (Loss)		 -11 -27 -33 -30 -23 -27 -42 -33 -45 -48 -50
Net Income / (Loss) Continuing Operations		 -11 -27 -33 -30 -23 -27 -42 -33 -45 -48 -50
Total Pre-Tax Income 		-11 -27 -33 -30 -23 -27 -42 -33 -44 -47 -50
Total Operating Income		 -12 -29 -34 -30 -24 -27 -41 -34 -45 -48 -51
Total Gross Profit		 8.87 1.41 1.16 1.07 0.51 0.80 1.50 2.77 0.64 0.90 0.70
Total Revenue		 8.87 1.41 1.16 1.07 0.51 0.80 1.50 2.77 0.64 0.90 0.70
Operating Revenue		 8.87 1.41 1.16 1.07 0.51 0.80 1.50 2.77 0.64 0.90 0.70
Total Cost of Revenue		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Operating Expenses		 21 30 35 31 24 27 43 37 46 49 51
Selling, General & Admin Expense		 7.20 7.80 8.64 7.22 5.07 5.60 8.50 7.26 11 11 15
Marketing Expense		 0.83 0.76 0.99 0.52 0.40 0.30 0.40 1.18 1.36 4.80 5.50
Research & Development Expense		 13 21 25 24 19 22 34 29 33 33 31
Total Other Income / (Expense), net		 0.73 1.26 0.73 -0.11 0.85 -0.50 -0.60 1.11 0.60 0.50 0.40
Interest & Investment Income		 0.73 1.26 0.73 -0.11 0.85 -0.50 -0.60 1.11 0.60 0.50 0.40
Income Tax Expense		 -0.01 0.05 0.00 0.00 0.01 0.00 0.10 0.00 0.37 0.20 0.20
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 -6.24 3.09 0.93 -3.78 3.82 -0.80 -7.00 0.84 0.25 4.50 0.90
Basic Earnings per Share		 ($0.05) ($0.28) ($0.34) ($0.32) ($0.28) ($0.26) ($0.31) ($0.24) ($0.32) ($0.11) ($0.12)
Weighted Average Basic Shares Outstanding		 95.12M 96.18M 96.17M 96.20M 97.00M 102.62M 134.48M 136.81M 139.57M 428.30M 433.54M
Diluted Earnings per Share		 ($0.05) ($0.28) ($0.34) ($0.32) ($0.28) ($0.26) ($0.31) ($0.24) ($0.32) ($0.11) ($0.12)
Weighted Average Diluted Shares Outstanding		 95.12M 96.18M 96.17M 96.20M 97.00M 102.62M 134.48M 136.81M 139.57M 428.30M 433.54M
Weighted Average Basic & Diluted Shares Outstanding		 96.43M 96.43M 96.50M 96.50M 0.00 136.95M 136.97M 169.11M 296.04M 296.04M 296.06M

Annual Cash Flow Statements for DBV Technologies

This table details how cash moves in and out of DBV Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 227 -70 -146 -17 53 19 -119 132 -68 -109 162
Net Cash From Operating Activities		 15 -63 -137 -156 -148 161 -108 -56 -80 -104 -121
Net Cash From Continuing Operating Activities		 -29 -98 -174 -179 -148 163 -108 -56 -80 -104 -121
Net Income / (Loss) Continuing Operations		 0.00 -120 -177 -190 -172 160 -98 -96 -73 -114 -147
Consolidated Net Income / (Loss)		 - -120 -177 -190 -172 160 -98 -96 -73 -114 -147
Depreciation Expense		 - - - - 2.60 - 8.38 13 -14 -0.93 3.19
Non-Cash Adjustments To Reconcile Net Income		 0.46 20 -0.67 0.86 18 1.13 3.96 5.12 6.12 6.01 21
Changes in Operating Assets and Liabilities, net		 13 2.52 4.01 10 3.45 2.33 -23 22 0.95 4.36 1.34
Net Cash From Investing Activities		 -5.81 -8.73 -9.41 -9.89 -5.66 2.87 -0.43 -0.10 -0.81 -0.76 -1.37
Net Cash From Continuing Investing Activities		 -5.81 -8.73 -9.41 -9.89 -5.66 0.06 -0.43 -0.10 -0.81 -0.76 -1.37
Purchase of Property, Plant & Equipment		 -4.90 -8.63 -9.06 -5.44 -5.57 - -0.91 -0.75 -0.68 -2.34 -0.53
Acquisitions		 - - - - -0.03 - -0.01 0.00 - -0.00 -0.01
Other Investing Activities, net		 - - - - - - 0.00 0.77 -0.13 1.58 -0.83
Net Cash From Financing Activities		 262 1.75 0.34 150 208 145 0.27 194 6.77 0.59 276
Net Cash From Continuing Financing Activities		 262 1.75 0.37 150 208 146 0.27 194 6.77 0.59 276
Issuance of Common Equity		 261 2.12 1.03 152 209 150 0.79 194 6.92 0.63 276
Other Financing Activities, net		 -0.02 -0.02 0.03 -0.16 0.17 -3.71 0.18 0.12 -0.15 -0.05 0.48
Effect of Exchange Rate Changes		 - - - - -0.89 - -11 -6.46 5.87 -4.27 8.08

Quarterly Cash Flow Statements for DBV Technologies

This table details how cash moves in and out of DBV Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -7.77 -40 -35 -20 -14 -20 90 -33 124 35 -54
Net Cash From Operating Activities		 -14 -35 -35 -22 -12 -20 -34 -32 -35 -49 -53
Net Cash From Continuing Operating Activities		 -14 -35 -35 -22 -12 -20 -34 -32 -35 -49 -53
Net Income / (Loss) Continuing Operations		 -11 -27 -33 -30 -23 -27 -42 -33 -45 -48 -50
Consolidated Net Income / (Loss)		 -11 -27 -33 -30 -23 -27 -42 -33 -45 -48 -50
Depreciation Expense		 -11 0.05 -1.46 -0.15 0.64 1.00 0.76 0.79 0.69 0.90 0.60
Non-Cash Adjustments To Reconcile Net Income		 1.24 3.24 1.57 2.33 -1.13 6.50 7.75 4.21 2.82 5.30 6.40
Changes in Operating Assets and Liabilities, net		 7.19 -11 -2.06 5.81 11 -0.10 -0.54 -4.27 6.14 -7.60 -9.10
Net Cash From Investing Activities		 -0.19 -2.13 0.69 -0.11 0.79 -0.40 -0.04 -0.24 -0.72 -0.30 -0.60
Net Cash From Continuing Investing Activities		 -0.19 -2.13 0.69 -0.11 0.79 -0.40 -0.04 -0.24 -0.71 -0.20 -0.70
Purchase of Property, Plant & Equipment		 -0.35 -1.34 -0.73 -0.40 0.13 0.00 -0.03 -0.12 -0.37 -0.40 -0.40
Other Investing Activities, net		 0.11 -0.80 1.42 0.29 0.50 -0.40 -0.01 -0.13 -0.34 0.20 -0.30
Net Cash From Financing Activities		 -0.19 -0.06 -0.03 0.01 0.68 0.00 117 0.13 159 89 0.10
Net Cash From Continuing Financing Activities		 -0.19 -0.06 -0.03 0.01 0.68 0.00 117 0.13 159 89 0.10
Issuance of Common Equity		 0.02 - - - 0.63 0.00 - 0.01 159 89 -0.10
Other Financing Activities, net		 -0.21 -0.06 -0.03 0.01 0.04 0.00 0.03 0.12 0.29 -0.20 0.20
Effect of Exchange Rate Changes		 6.29 -2.96 -0.90 2.79 -3.20 0.50 7.24 -0.83 1.16 -4.50 -1.10

Annual Balance Sheets for DBV Technologies

This table presents DBV Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 373 302 214 197 272 272 147 247 183 66 234
Total Current Assets		 364 286 21 24 205 207 114 223 159 44 213
Cash & Equivalents		 351 270 - - 193 196 77 209 141 32 194
Other Current Assets		 13 15 21 24 9.01 8.79 37 14 18 12 19
Plant, Property, & Equipment, net		 6.06 13 21 23 25 25 18 15 13 11 10
Total Noncurrent Assets		 3.05 2.99 169 149 42 40 14 8.35 11 9.97 10
Other Noncurrent Operating Assets		 2.95 2.89 169 149 42 40 14 8.34 11 9.93 10
Total Liabilities & Shareholders' Equity		 373 302 530 780 272 272 147 247 183 66 234
Total Liabilities		 23 47 530 780 79 66 47 52 43 38 65
Total Current Liabilities		 17 31 671 945 54 53 31 30 37 31 58
Accounts Payable		 11 14 20 33 24 20 11 14 23 22 41
Current Employee Benefit Liabilities		 - - - - - - - - - - 0.20
Other Current Liabilities		 6.34 15 648 910 29 32 19 15 13 8.45 17
Total Noncurrent Liabilities		 5.63 16 -141 -164 25 14 16 23 5.46 7.14 6.90
Noncurrent Employee Benefit Liabilities		 - - - - - - - - - 0.84 1.50
Other Noncurrent Operating Liabilities		 0.53 12 -143 -166 24 2.88 16 23 5.46 6.30 5.40
Total Equity & Noncontrolling Interests		 350 376 0.00 0.00 193 1,010 99 194 140 27 169
Total Preferred & Common Equity		 398 376 0.00 0.00 193 1,010 99 194 140 27 169
Total Common Equity		 -40 255 0.00 0.00 193 13 99 194 140 27 169
Common Stock		 2.63 2.59 - - 1,009 6.52 365 469 388 327 568
Retained Earnings		 - - - - -799 - -259 -260 -239 -286 -393
Treasury Stock		 - - - - -0.23 - -1.23 -1.11 -1.26 -1.31 -0.80
Accumulated Other Comprehensive Income / (Loss)		 - - - - 0.11 - 0.52 0.78 0.74 0.91 0.50
Other Equity Adjustments		 -43 -54 - - -17 6.23 -6.14 -15 -8.87 -13 -5.90

Quarterly Balance Sheets for DBV Technologies

This table presents DBV Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 218 190 146 114 93 51 143 110 266 223
Total Current Assets		 196 169 120 90 69 29 121 89 247 202
Cash & Equivalents		 174 149 102 66 46 13 103 70 229 175
Other Current Assets		 22 20 18 24 22 16 18 19 18 27
Plant, Property, & Equipment, net		 14 13 13 13 13 11 11 11 9.90 9.70
Total Noncurrent Assets		 7.84 7.42 13 11 11 11 11 11 9.70 12
Other Noncurrent Operating Assets		 7.78 7.36 13 11 11 11 11 11 9.60 12
Total Liabilities & Shareholders' Equity		 218 190 146 114 93 51 143 110 266 223
Total Liabilities		 53 46 34 35 39 48 57 58 58 63
Total Current Liabilities		 33 31 26 27 31 40 49 49 52 54
Accounts Payable		 19 17 18 20 23 34 41 40 40 39
Current Employee Benefit Liabilities		 - - - - - - - - - 0.40
Other Current Liabilities		 14 15 8.41 7.18 8.04 5.53 7.64 8.67 11 15
Total Noncurrent Liabilities		 20 14 7.76 7.71 8.11 7.31 7.78 8.16 6.70 8.50
Noncurrent Employee Benefit Liabilities		 - - - - - - - - 1.60 1.60
Other Noncurrent Operating Liabilities		 20 14 7.76 7.71 8.11 7.31 7.78 8.16 5.10 6.90
Total Equity & Noncontrolling Interests		 164 144 112 79 54 2.87 86 53 208 160
Total Preferred & Common Equity		 164 144 112 79 54 2.87 86 53 208 160
Total Common Equity		 164 144 112 79 54 2.87 86 53 208 160
Common Stock		 387 387 390 325 327 329 407 407 660 442
Retained Earnings		 -211 -228 -266 -233 -263 -313 -315 -348 -441 -270
Treasury Stock		 -1.08 -1.16 -1.33 -1.36 -1.35 -1.26 -1.24 -1.12 -1.00 -0.80
Accumulated Other Comprehensive Income / (Loss)		 0.69 0.76 0.68 0.75 0.71 1.04 0.86 0.50 0.40 0.50
Other Equity Adjustments		 -11 -15 -12 -13 -9.07 -12 -5.20 -5.68 -10 -11

Annual Metrics And Ratios for DBV Technologies

This table displays calculated financial ratios and metrics derived from DBV Technologies' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 0.00 24,990,822.00 30,157,777.00 47,028,510.00 54,936,687.00 55,011,687.00 94,137,145.00 96,431,770.00 - 169,113,619.00
DEI Adjusted Shares Outstanding		 0.00 0.00 2,499,082.00 3,015,778.00 4,702,851.00 5,493,669.00 5,501,169.00 9,413,715.00 9,643,177.00 - 169,113,619.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 -70.99 -63.03 -36.58 -29.06 -20.01 -11.09 -6.95 - -0.83
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -35 -85 -122 -133 -120 -111 -69 -68 -54 -82 -103
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -37.86% -291.05% -60.59%
Earnings before Interest and Taxes (EBIT)		 -49 -122 -174 -190 -171 -158 -99 -97 -76 -117 -147
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -48 -122 -174 -190 -168 -158 -90 -83 -90 -118 -144
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -72 181 135 -702 -130 -71 -30 -68 -77 -83
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 3.84 -9.45 -313 -581 1.39 21 22 -15 -0.04 -4.41 -24
Increase / (Decrease) in Invested Capital		 0.00 -13 -303 -268 582 19 1.68 -37 15 -4.38 -20
Book Value per Share		 $0.00 $0.00 $0.00 $0.00 $6.41 $0.27 $1.80 $2.07 $1.46 $0.28 $1.00
Tangible Book Value per Share		 $0.00 $0.00 ($0.01) $0.00 $6.40 $0.27 $1.80 $2.07 $1.46 $0.28 $1.00
Total Capital		 355 381 4.99 2.84 195 1,021 100 194 141 28 170
Total Debt		 5.26 4.88 4.99 2.84 1.46 11 0.51 0.00 1.14 0.65 1.12
Total Long-Term Debt		 5.10 4.26 2.19 1.46 0.81 11 0.00 0.00 0.00 0.00 0.00
Net Debt		 -346 -265 4.99 2.84 -192 -185 -77 -209 -140 -32 -193
Capital Expenditures (CapEx)		 4.90 8.63 9.06 5.44 5.57 -0.06 0.31 0.75 0.68 2.34 0.53
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -4.74 -13 -647 -919 -42 -42 6.20 -16 -19 -19 -38
Debt-free Net Working Capital (DFNWC)		 347 256 -647 -919 151 155 83 194 123 14 156
Net Working Capital (NWC)		 346 256 -650 -920 151 155 83 194 122 13 155
Net Nonoperating Expense (NNE)		 14 35 56 57 52 49 29 29 19 32 44
Net Nonoperating Obligations (NNO)		 -346 -385 -313 -581 -192 -989 -77 -209 -140 -32 -193
Total Depreciation and Amortization (D&A)		 1.17 0.00 0.00 0.00 2.60 0.00 8.38 13 -14 -0.93 3.19
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 ($5.90) $0.00 ($2.48) ($7.60) ($1.17) ($1.05)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 12.50M 15.08M 23.51M 27.47M 0.00 38.69M 9.51M 97.00M 139.57M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 ($5.90) $0.00 ($2.48) ($7.60) ($1.17) ($1.05)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 12.50M 15.08M 23.51M 27.47M 0.00 38.69M 9.51M 97.00M 139.57M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 ($5.90) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 12.50M 15.08M 23.51M 27.05M 0.00 47.07M 9.64M 0.00 296.04M
Normalized Net Operating Profit after Tax (NOPAT)		 -35 -85 -122 -133 -120 -94 -69 -68 -54 -82 -103
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for DBV Technologies

This table displays calculated financial ratios and metrics derived from DBV Technologies' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 96,431,770.00 96,431,770.00 96,434,369.00 96,498,927.00 - 96,501,526.00 136,948,872.00 136,973,697.00 169,113,619.00 296,042,447.00 296,042,447.00
DEI Adjusted Shares Outstanding		 9,643,177.00 9,643,177.00 9,643,437.00 19,299,785.00 - 19,300,305.00 136,948,872.00 136,973,697.00 169,113,619.00 296,042,447.00 296,042,447.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.51 -3.16 -3.53 -1.38 - -1.36 -0.25 -0.25 -0.27 -0.18 -0.17
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 780.00% -35.87% -49.26% -54.81% -94.24% -46.48% 26.18% 158.77% - 12.50% -53.33%
EBITDA Growth		 12.11% -33.24% -44.23% -40.39% -1.65% 9.96% -14.29% -9.86% - -83.59% -23.76%
EBIT Growth		 68.64% -34.93% -34.96% -66.00% -100.16% 6.79% -21.48% -13.02% - -80.08% -23.11%
NOPAT Growth		 68.64% -34.93% -34.96% -66.00% -100.16% 6.79% -21.48% -13.02% - -80.08% -23.11%
Net Income Growth		 71.49% -32.99% -36.60% -81.90% -105.75% 0.97% -26.45% -8.94% - -75.65% -20.29%
EPS Growth		 71.49% -32.99% -36.60% -81.90% -460.00% 7.14% 8.82% 25.00% - 57.69% 61.29%
Operating Cash Flow Growth		 42.70% -66.46% -37.26% -14.73% 10.48% 43.31% 3.33% -44.43% - -149.24% -55.16%
Free Cash Flow Firm Growth		 -317.22% -749.54% -403.78% -315.46% 46.52% 102.02% 101.00% 99.86% - -2,634.80% -7,852.94%
Invested Capital Growth		 99.75% 176.76% 236.44% 254.92% -11,829.73% -192.60% -220.52% -300.62% - -117.51% 9.28%
Revenue Q/Q Growth		 274.11% -84.14% -17.48% -7.67% -52.33% 47.36% 94.56% 89.35% - 39.75% -22.22%
EBITDA Q/Q Growth		 -5.23% -24.76% -23.86% 13.67% 23.81% -10.52% -57.22% 17.02% - -5.95% -6.38%
EBIT Q/Q Growth		 34.75% -139.56% -18.50% 10.38% 21.32% -11.55% -54.45% 16.62% - -6.33% -5.64%
NOPAT Q/Q Growth		 34.75% -139.56% -18.50% 10.38% 21.32% -11.55% -54.45% 16.62% - -6.33% -5.64%
Net Income Q/Q Growth		 33.16% -144.46% -21.10% 8.07% 24.40% -17.66% -54.64% 20.80% - -6.18% -5.88%
EPS Q/Q Growth		 33.16% -144.46% -21.10% 8.07% 12.50% 7.14% -19.23% 22.58% - 65.63% -9.09%
Operating Cash Flow Q/Q Growth		 30.08% -153.49% -1.10% 35.97% 45.44% -60.53% -72.39% 4.34% - -39.60% -7.13%
Free Cash Flow Firm Q/Q Growth		 -178.86% -87.93% -7.75% 26.43% 64.10% 107.10% -46.50% -110.01% - -91.58% -63.95%
Invested Capital Q/Q Growth		 99.28% 27,475.68% 30.93% -39.93% -155.41% -112.48% -70.42% 0.02% - 15.70% 28.92%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00% 100.00%
EBITDA Margin		 -257.46% -2,025.94% -3,041.00% -2,843.28% -4,544.62% -3,408.50% -2,754.33% -1,207.10% - -5,222.22% -7,142.86%
Operating Margin		 -134.34% -2,029.71% -2,914.90% -2,829.10% -4,669.47% -3,534.93% -2,806.21% -1,235.65% - -5,322.22% -7,228.57%
EBIT Margin		 -134.34% -2,029.71% -2,914.90% -2,829.10% -4,669.47% -3,534.93% -2,806.21% -1,235.65% - -5,322.22% -7,228.57%
Profit (Net Income) Margin		 -126.05% -1,943.50% -2,852.37% -2,839.74% -4,503.91% -3,596.15% -2,858.36% -1,195.53% - -5,288.89% -7,200.00%
Tax Burden Percent		 99.95% 100.18% 100.00% 100.00% 100.03% 100.00% 100.28% 100.00% - 100.42% 100.40%
Interest Burden Percent		 93.88% 95.58% 97.85% 100.38% 96.43% 101.73% 101.57% 96.75% - 98.96% 99.21%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% -15,915.59% -17,551.27% 0.00% -23,075.06% 0.00% 0.00% - 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% -15,907.73% -17,541.83% 0.00% -23,060.21% 0.00% 0.00% - 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 15,676.17% 17,291.67% 0.00% 22,909.20% 0.00% 0.00% - 0.00% 0.00%
Return on Equity (ROE)		 -43.47% -54.69% -239.42% -259.60% -135.96% -165.86% -148.09% -234.14% - -158.89% -142.68%
Cash Return on Invested Capital (CROIC)		 0.00% -809.57% -662.01% -1,084.14% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Operating Return on Assets (OROA)		 -9.84% -160.11% -242.78% -250.34% -155.91% -125.85% -82.81% -66.81% - -192.63% -194.64%
Return on Assets (ROA)		 -9.23% -153.30% -237.57% -251.29% -150.38% -128.03% -84.35% -64.64% - -191.42% -193.87%
Return on Common Equity (ROCE)		 -43.47% -54.69% -239.42% -259.60% -135.96% -165.86% -148.09% -234.14% - -158.93% -142.72%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -71.21% 0.00% 0.00% 0.00% -3,955.86% 0.00% 0.00% - 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -8.34 -20 -24 -21 -17 -19 -29 -24 -32 -34 -35
NOPAT Margin		 -94.04% -1,420.80% -2,040.43% -1,980.37% -3,268.63% -2,474.45% -1,964.35% -864.96% - -3,725.56% -5,060.00%
Net Nonoperating Expense Percent (NNEP)		 -1.63% -5.01% -7.86% -9.44% -7.34% -14.85% -15.59% -15.96% - -11.70% -10.81%
Return On Investment Capital (ROIC_SIMPLE)		 -5.90% -17.90% -29.81% -39.02% -59.57% -520.17% -32.99% -44.55% -18.56% -16.05% -22.08%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
SG&A Expenses to Revenue		 81.09% 554.66% 744.44% 673.51% 992.56% 747.14% 577.68% 261.68% - 1,166.67% 2,085.71%
R&D to Revenue		 143.96% 1,521.18% 2,185.53% 2,207.28% 3,699.22% 2,852.99% 2,299.86% 1,031.54% - 3,711.11% 4,457.14%
Operating Expenses to Revenue		 234.35% 2,129.64% 3,014.90% 2,929.20% 4,769.47% 3,634.79% 2,906.14% 1,335.65% - 5,422.22% 7,328.57%
Earnings before Interest and Taxes (EBIT)		 -12 -29 -34 -30 -24 -27 -41 -34 -45 -48 -51
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -23 -29 -35 -30 -23 -26 -40 -33 -44 -47 -50
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.65 0.65 0.49 1.25 2.18 45.82 14.55 25.92 - 29.74 6.05
Price to Tangible Book Value (P/TBV)		 0.65 0.65 0.49 1.25 2.18 46.28 14.55 25.93 - 29.75 6.05
Price to Revenue (P/Rev)		 5.83 4.83 2.80 5.40 14.37 37.64 330.03 248.91 - 1,078.16 196.72
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 2.70 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 1.72 6.71 34.14 303.14 236.40 - 1,038.38 161.29
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.01 0.00 0.00 0.01 0.02 0.25 0.01 0.02 - 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Financial Leverage		 -1.04 -1.01 -0.99 -0.99 -1.03 -0.99 -1.02 -1.08 - -1.14 -1.12
Leverage Ratio		 1.28 1.30 1.36 1.43 1.48 1.72 1.56 1.90 - 1.50 1.49
Compound Leverage Factor		 1.21 1.25 1.33 1.43 1.43 1.75 1.58 1.84 - 1.49 1.47
Debt to Total Capital		 0.81% 0.00% 0.48% 0.69% 2.33% 19.79% 1.14% 1.86% - 0.48% 0.00%
Short-Term Debt to Total Capital		 0.81% 0.00% 0.48% 0.69% 2.33% 19.79% 1.14% 1.86% - 0.48% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Common Equity to Total Capital		 99.19% 100.00% 99.52% 99.31% 97.67% 80.21% 98.86% 98.14% - 99.55% 100.04%
Debt to EBITDA		 -0.01 0.00 0.00 0.00 -0.01 -0.01 -0.01 -0.01 - -0.01 0.00
Net Debt to EBITDA		 1.55 0.00 0.61 0.39 0.27 0.11 0.85 0.56 - 1.38 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Debt to NOPAT		 -0.02 0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 - -0.01 0.00
Net Debt to NOPAT		 2.62 0.00 1.02 0.63 0.39 0.15 1.20 0.78 - 1.94 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Altman Z-Score		 0.13 -1.07 -2.39 -3.38 -6.07 -8.96 9.76 9.30 - 61.53 7.65
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - -0.03% -0.03%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.26 4.51 3.29 2.22 1.43 0.72 2.45 1.80 - 4.76 3.72
Quick Ratio		 3.79 3.83 2.42 1.50 1.04 0.32 2.09 1.41 - 4.42 3.22
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -23 -43 -47 -34 -12 0.88 0.47 -0.05 -12 -23 -37
Operating Cash Flow to CapEx		 -3,888.07% -2,598.65% -4,791.39% -5,670.96% 0.00% -196,680.00% -105,953.13% -27,722.22% - -12,275.00% -13,150.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.07 0.08 0.08 0.09 0.03 0.04 0.03 0.05 - 0.04 0.03
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Fixed Asset Turnover		 1.13 1.08 1.02 0.96 0.35 0.29 0.32 0.47 - 0.55 0.48
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -0.04 10 13 7.97 -4.41 -9.38 -16 -16 -24 -20 -15
Invested Capital Turnover		 -2.13 -9.75 7.80 8.86 -1.87 9.33 -2.79 -1.37 - -0.39 -0.32
Increase / (Decrease) in Invested Capital		 15 23 23 13 -4.38 -20 -29 -24 -20 -11 1.48
Enterprise Value (EV)		 -48 -29 -27 21 28 119 1,152 1,301 - 5,956 796
Market Capitalization		 92 72 39 68 60 132 1,254 1,370 - 6,184 971
Book Value per Share		 $1.46 $1.16 $0.82 $0.56 $0.28 $0.03 $0.64 $0.39 $1.00 $0.70 $0.54
Tangible Book Value per Share		 $1.46 $1.16 $0.82 $0.56 $0.28 $0.03 $0.64 $0.39 $1.00 $0.70 $0.54
Total Capital		 141 112 79 54 28 3.58 87 54 170 209 160
Total Debt		 1.14 0.00 0.38 0.37 0.65 0.71 1.00 1.00 1.12 1.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -140 -102 -66 -46 -32 -12 -102 -69 -193 -228 -175
Capital Expenditures (CapEx)		 0.35 1.34 0.73 0.40 -0.13 0.01 0.03 0.12 0.37 0.40 0.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -19 -8.45 -3.26 -8.22 -19 -23 -30 -29 -38 -33 -27
Debt-free Net Working Capital (DFNWC)		 123 93 63 38 14 -11 73 40 156 196 148
Net Working Capital (NWC)		 122 93 63 38 13 -11 72 39 155 195 148
Net Nonoperating Expense (NNE)		 2.84 7.35 9.43 9.21 6.31 8.45 13 9.17 13 14 15
Net Nonoperating Obligations (NNO)		 -140 -102 -66 -46 -32 -12 -102 -69 -193 -228 -175
Total Depreciation and Amortization (D&A)		 -11 0.05 -1.46 -0.15 0.64 0.95 0.76 0.79 0.69 0.90 0.60
Debt-free, Cash-free Net Working Capital to Revenue		 -118.56% -56.53% -23.57% -65.69% -446.88% -671.69% -799.61% -534.96% - -580.54% -553.08%
Debt-free Net Working Capital to Revenue		 780.26% 622.98% 455.75% 305.42% 335.00% -301.03% 1,915.65% 734.11% - 3,415.27% 2,990.28%
Net Working Capital to Revenue		 772.99% 622.98% 453.00% 302.43% 319.25% -321.30% 1,889.40% 715.92% - 3,397.84% 2,990.28%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.50) ($2.80) ($1.70) ($1.60) ($0.28) ($0.26) ($0.31) ($0.24) ($0.32) ($0.11) ($0.12)
Adjusted Weighted Average Basic Shares Outstanding		 9.51M 9.62M 19.23M 19.24M 97.00M 102.62M 134.48M 136.81M 139.57M 428.30M 433.54M
Adjusted Diluted Earnings per Share		 ($0.50) ($2.80) ($1.70) ($1.60) ($0.28) ($0.26) ($0.31) ($0.24) ($0.32) ($0.11) ($0.12)
Adjusted Weighted Average Diluted Shares Outstanding		 9.51M 9.62M 19.23M 19.24M 97.00M 102.62M 134.48M 136.81M 139.57M 428.30M 433.54M
Adjusted Basic & Diluted Earnings per Share		 ($0.50) $0.00 $0.00 $0.00 ($0.28) $0.00 $0.00 $0.00 ($0.32) $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 9.64M 9.64M 19.30M 19.30M 0.00 136.95M 136.97M 169.11M 296.04M 296.04M 296.06M
Normalized Net Operating Profit after Tax (NOPAT)		 -8.34 -20 -24 -21 -17 -19 -29 -24 -32 -34 -35
Normalized NOPAT Margin		 -94.04% -1,420.80% -2,040.43% -1,980.37% -3,268.63% -2,474.45% -1,964.35% -864.96% - -3,725.56% -5,060.00%
Pre Tax Income Margin		 -126.12% -1,940.09% -2,852.37% -2,839.74% -4,502.54% -3,596.15% -2,850.38% -1,195.53% - -5,266.67% -7,171.43%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

DBV Technologies (NASDAQ: DBVT) continues to look like a clinical-stage biotech with very limited product revenue, heavy operating losses, and a balance sheet that has been reshaped dramatically by equity issuance over the past year.

Revenue remains minimal. In Q1 2026, the company reported just $0.9 million in revenue, up from $0.6 million in Q4 2025 and $0.8 million in Q1 2025. That’s a small base, which means DBVT is still far from being self-funding through sales.

Losses remain substantial, but have improved slightly versus a year ago. Q1 2026 net loss was $47.6 million, compared with $44.8 million in Q4 2025 and $27.1 million in Q1 2025. On a sequential basis, the loss widened again, mainly because spending stayed elevated while revenue stayed tiny.

Operating expenses are still the main issue. In Q1 2026, DBVT reported:

  • R&D expense: $33.4 million
  • SG&A expense: $10.5 million
  • Marketing expense: $4.8 million

Those costs produced an operating loss of $47.9 million for the quarter, which shows the company is still investing heavily in development and commercialization efforts without offsetting revenue.

Cash burn remains significant. Operating cash flow was negative $49.1 million in Q1 2026, versus negative $35.2 million in Q4 2025 and negative $19.7 million in Q1 2025. That is a clear sign that the company’s cash usage accelerated in the latest quarter.

Financing activity kept the cash balance up. DBVT raised $89.1 million from common equity issuance in Q1 2026, which helped offset operating losses and left the company with $229.2 million in cash and equivalents at quarter-end, up from $69.8 million in Q3 2025.

The balance sheet is stronger on cash, but equity dilution is a real cost. Common equity jumped to $208.0 million at Q1 2026, versus $52.9 million in Q3 2025. That improvement in liquidity came largely from repeated share issuance, which can weigh on existing shareholders.

Liability levels are manageable for now. Total liabilities were $58.4 million in Q1 2026, compared with $57.6 million in Q3 2025 and $47.7 million in Q1 2025. The company does not appear overleveraged, but it is still dependent on external funding.

  • Cash and equivalents increased to $229.2 million in Q1 2026, giving DBVT a solid near-term liquidity cushion.
  • Revenue improved year over year from $0.8 million in Q1 2025 to $0.9 million in Q1 2026, though the absolute level remains very small.
  • Interest and investment income remained positive at $0.5 million in Q1 2026, helping partially offset operating losses.
  • Total liabilities were relatively stable around the high-$50 million range, suggesting no major balance-sheet stress from debt.
  • Basic and diluted EPS were both -$0.11 in Q1 2026, reflecting ongoing losses but not a surprise for a development-stage biotech.
  • Operating cash burn widened to negative $49.1 million in Q1 2026, worse than the prior quarter.
  • R&D spending stayed very high at $33.4 million, which keeps pressure on profitability and cash flow.
  • Share issuance remains a recurring funding source, which can dilute existing investors.
  • Revenue is still too small to support the cost structure, leaving DBVT dependent on financing and clinical progress.

Bottom line: DBV Technologies ended Q1 2026 with a much larger cash cushion than it had a year ago, but that strength came from equity financing rather than operating progress. The company still has deep losses, heavy cash burn, and minimal revenue, so investors should view the stock as highly dependent on future clinical and financing developments.

07/28/26 03:19 AM ETAI Generated. May Contain Errors.

DBV Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, DBV Technologies' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Over the last 10 years, DBV Technologies' net income changed from -$48.54 million in 2015 to -$146.95 million in 2025, a change of 202.7%. See where experts think DBV Technologies is headed by visiting DBV Technologies' forecast page.

DBV Technologies' total operating income in 2025 was -$147.06 million, based on the following breakdown:
  • Total Gross Profit: $5.64 million
  • Total Operating Expenses: $152.69 million

Over the last 10 years, DBV Technologies' total revenue changed from $6.70 million in 2015 to $5.64 million in 2025, a change of -15.9%.

DBV Technologies' total liabilities were at $64.90 million at the end of 2025, a 69.6% increase from 2024, and a 181.7% increase since 2015.

In the past 10 years, DBV Technologies' cash and equivalents has ranged from $0.00 in 2017 to $351.37 million in 2015, and is currently $194.20 million as of their latest financial filing in 2025.

Over the last 10 years, DBV Technologies' book value per share changed from 0.00 in 2015 to 1.00 in 2025, a change of 99.8%.


Related Companies

Financial statements for NASDAQ:DBVT last updated on 7/18/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
The 1974 Kissinger "Secret" Wall Street Never Decoded
In 1974, Henry Kissinger helped create the U.S.-Saudi Arabia Joint Commission on Economic Cooperation - a litt...
Golden Portfolio | Sponsoredtc pixel
What Elon told his top shareholders in Texas
Late last year, Elon Musk gathered top shareholders at Tesla's Texas Gigafactory to unveil a plan to double Am...
Banyan Hill Publishing | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
A storm is coming
The U.S. dollar has sunk to near a four-year low, while the Bureau of Economic Analysis prepares a change to h...
Stansberry Research | Sponsoredtc pixel
Universal basic income is not impossible. It exist (kind of)
Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...
Freedom Financial | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel